Sintx Technologies Inc. (SINT)
3.22
0.02 (0.63%)
At close: Jan 15, 2025, 10:59 AM
Company Description
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States.
The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone.
The company was formerly known as Amedica Corporation.
Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Sintx Technologies Inc.
| Country | United States |
| IPO Date | Feb 13, 2014 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 43 |
| CEO | Eric K. Olson |
Contact Details
Address: 1885 West 2100 South Salt Lake City, Utah United States | |
| Website | https://www.sintx.com |
Stock Details
| Ticker Symbol | SINT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001269026 |
| CUSIP Number | 829392307 |
| ISIN Number | US8293926049 |
| Employer ID | 00-0000000 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Eric K. Olson | President, Chief Executive Officer & Director |
| Dr. Ryan Bock Ph.D. | Chief Technology Officer |
| Ann Kutsch | President of SINTX Technology Assessment & Transfer |
| Gina Moss | Director of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 23, 2024 | 8-K | Current Report |
| Dec 13, 2024 | 8-K | Current Report |
| Nov 29, 2024 | 8-K | Current Report |
| Nov 26, 2024 | DEFA14A | Filing |
| Nov 19, 2024 | 8-K | Current Report |
| Nov 18, 2024 | 8-K | Current Report |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | DEF 14A | Filing |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 01, 2024 | 8-K | Current Report |